Impact of MDR on clinical investigations

In this video the major changes of the MDR compared to the current laws for clinical investigations with medical devices with respect to the review and conduct of clinical investigations is highlighted.

 

Transcript:

 

In this video, I would like to highlight the major changes of the MDR compared to the current laws for clinical investigations with medical devices with respect to the regulatory submission in the Netherlands, review and conduct of clinical investigations.
The 4 key changes of the MDR are:
  • The definition of a medical device is slightly altered.
  • The classification rules have been changed, allowing some medical devices to be placed into a higher risk class as described in annex 8 of the MDR
  • The requirements for obtaining a CE mark are higher which may result that more clinical data is needed as described in article 61 of the MDR.
  • The MDR describes different legal frameworks for clinical investigations depending on the purpose of the investigation.

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Other articles

Clinical Investigations

Safety reporting under MDR in The Netherlands part III

In this video, the following question is briefly answered: “When does vigilance reporting apply and who is responsible for this process?”   Transcript:   In this “trilogy” we talk about the safety reporting of different legal frameworks in The Netherlands.   The last 2 weeks we talked about safety reporting for clinical investigations that are

Clinical Investigations

Safety reporting under MDR in The Netherlands part II

In this video, the following question is briefly answered: “How do clinical investigations under article 82 comply with safety reporting in The Netherlands?”   Transcript:   Last week, we began looking at safety reporting. Today, we’re going to briefly focus on the following follow-up question:   How do clinical investigations under article 82 comply with

Scroll to Top